Hyperbolic correlation between insulin sensitivity and insulin secretion fades away in lean subjects with superb glucose regulation

Endocrine Journal

Volumn 59, Issue 2, 2012, Pages 127-136

  Aizawa, Toru ^a   Yamada, Masayuki ^b   Katakura, Masafumi ^c   Funase, Yoshiko ^a   Yamashita, Koh ^a   Yamauchi, Keishi ^a  

^a Specified Medical Corporation Jisenkai Aizawa Hospital   (Japan)

^b KISSEI PHARMACEUTICAL CO LTD   (Japan)

^c Chikuma Central Hospital   (Japan)

Author keywords

Beta cell function; Glucose tolerance; Hyperbolic law; Insulin sensitivity

Indexed keywords

GLUCOSE; IMMUNOREACTIVE INSULIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PATIENT CODING; REGRESSION ANALYSIS;

ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; THINNESS;

EID: 84857774059     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0162     Document Type: Article

References (39)

1. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467.
2. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr (1993) Quantification of the relationship between insulin sensitivity and betacell function in human subjects. Evidence for a hyper bolic function. Diabetes 42: 1663-1672.
3. Stumvoll M (2004) Control of glycaemia: from molecules to men. Minkowski Lecture 2003. Diabetologia 47: 770-781.
4. Ferrannini E, Mari A (2004) Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia 47: 943-956.
5. Sato Y, Komatsu M, Katakura M, Ohfusa H, Yamada S, Yamauchi K, Hiramatsu K, Ichikawa K, Aizawa T, Hashizume K (2002) Diminution of early insulin response to glucose in subjects with normal but minimally elevated fasting plasma glucose. Evidence for early beta-cell dysfunction. Diabet Med 19: 566-571.
6. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA; San Antonio metabolism study (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47: 31-39.
7. Godsland IF, Jeffs JA, Johnston DG (2004) Loss of beta cell function as fasting glucose increases in the non-diabetic range. Diabetologia 47: 1157-1166.
8. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA (2005) Beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90: 493-500.
9. Bergman RN, Ader M, Huecking K, Van Citters G (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51 Suppl 1: S212-220.
10. Festa A, Williams K, D'Agostino R Jr, Wagenknecht LE, Haffner SM (2006) The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 55: 1114-1120.
11. Mari A, Tura A, Pacini G, Kautzky-Willer A, Ferrannini E (2008) Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes. Diabet Med 25: 671-677.
12. Mari A, Tura A, Natali A, Laville M, Laakso M, Gabriel R, Beck-Nielsen H, Ferrannini E; RISC Investigators (2010) Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia 53: 749-756.
13. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B (2005) Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 48: 993-1001.
14. Utzschneider KM, Prigeon RL, Carr DB, Hull RL, Tong J, Shofer JB, Retzlaff BM, Knopp RH, Kahn SE (2006) Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29: 356-362.
15. Sakaue S, Ishimaru S, Ikeda D, Ohtsuka Y, Honda T, Suzuki J, Kawakami Y, Ishii J, Nishimura M (2007) Estimation of beta-cell function from the data of the oral glucose tolerance test. Am J Physiol Endocrinol Metab 292: E1575-1580.
16. Cobelli C, Toffolo GM, Dalla Man C, Campioni M, Denti P, Caumo A, Butler P, Rizza R (2007) Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab 293: E1-E15.
17. Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B (2008) Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity 16: 1901-1907.
18. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE (2009) Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32: 335-341.
19. Katakura M, Komatsu M, Sato Y, Hashizume K, Aizawa T (2004) Primacy of beta-cell dysfunction in the development of hyperglycemia: a study in the Japanese general population. Metabolism 53: 949-953.
20. Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W (1998) Influence of glucagon-like peptide 1 on fasting glycaemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure. Diabetes Care 21: 1925-1931.
21. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available from http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf.
22. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
23. DeFronzo RA, Matsuda M (2010) Reduced time points to calculate the composite index. Diabetes Care 33: e93.
24. Kosaka K, Hagura R, Kuzuya T, Kuzuya N (1974) Insulin secretory response of diabetics during the period of improvement of glucose tolerance to normal range. Diabetologia 10: 775-782.
25. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, Renn W, Gerich J (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295-301.
26. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H (1996) Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med 13 (9 Suppl 6): S109-119.
27. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA (2006) Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55: 1430-1435.
28. Sokal RR, Rohlf FJ (2011) Biometry (4th), WH Freeman and Company, New York.
29. Falster DS, Warton DI, Wright IJ. SMATR: standardized major axis tests and routines, ver 2.0. Available from http://www.bio.mq.edu.au/ecology/SMATR/.
30. Warton DI, Wright IJ, Falster DS, Westoby M (2006) Bivariate line-fitting methods for allometry. Biol Rev Camb Philos Soc 81: 259-291.
31. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Statist 6: 65-70.
32. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus (1997) Diabetes Care 20: 1183-1197.
33. Bergman RN, Finegood DT, Ader M (1985) Assessment of insulin sensitivity in vivo. Endocr Rev 6: 45-86.
34. Lorenzo C, Wagenknecht LE, Rewers MJ, Karter AJ, Bergman RN, Hanley AJ, Haffner SM (2010) Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 33: 2098-2103.
35. Holst JJ, Gromada J (2004) Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 287: E199-E206.
36. Meier JJ, Nauck MA (2010) Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes 59: 1117-1125.
37. D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW (1994) Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest 93: 2263-2266.
38. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K (1992) Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41: 1540-1546.
39. Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagata I, Florant GL, Tokuyama K (1994) Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis. Metabolism 43: 714-718.